product summary
Loading...
company name :
Toronto BioScience
product type :
antibody
product name :
Plasminogen activator inhibitor type-1 (human), rabbit polyclonal
catalog :
11070
quantity :
100 μg
price :
181 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
ELISA
more info or order :
citations: 4
Reference
Marudamuthu A, Shetty S, Bhandary Y, Karandashova S, Thompson M, Sathish V, et al. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs. J Biol Chem. 2015;290:9428-41 pubmed publisher
Daniel A, Timmerman I, Kovacevic I, Hordijk P, Adriaanse L, Paatero I, et al. Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin Trafficking. PLoS ONE. 2015;10:e0145684 pubmed publisher
Jacobs M. A review of the development of an ergonomically balanced chair. J Manipulative Physiol Ther. 1987;10:335-6 pubmed
Xu K, Liu X, Yang F, Cui D, Shi Y, Shen C, et al. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. PLoS ONE. 2013;8:e79150 pubmed publisher
product information
Catalog Number :
11070
Product Name :
Plasminogen activator inhibitor type-1 (human), rabbit polyclonal
Host Species :
Rabbit
Clonality :
Polyclonal
Conjugation :
Purified
Product Type :
Antibody
Size :
100 μg
List Price (USD) :
181 USD
list of Pubmed id :
26714278, 25648892, 24223897, 3437240
Isotype :
Rabbit IgG
Product Description :
This rabbit polyclonal antibody can detect human plasminogen activator inhibitor type-1 (PAI-1) by ELISA.
SpeciesSummary :
Human specificity
Background :
Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of tissue-type and urokinase-type plasminogen activator, playing a major role in fibrinolysis. PAI-1 is mainly produced by the endothelium, but is also secreted by other tissue types, such as adipose tissue. It is normally present at low levels in plasma and tissue, but its expression and release increased in various disease states (such as a number of forms of cancer), as well as in obesity and the metabolic syndrome. PAI-1 is also involved in the pathophysiology of renal, pulmonary, cardiovascular, and metabolic diseases. Elevated local or systemic PAI-1 can also exacerbate such pathologic conditions.
ALTnames :
Plasminogen activator inhibitor-1 (PAI-1), also known as PAI, PAI1, PLANH1, and SERPINE1
Immunogen :
Recombinant full-length human PAI-1 expressed in E.coli.
Specificity :
Human
Buffer :
Solution in PBS
Uses :
ELISA - This antibody can be used in ELISA with the appropriate secondary reagents to detect human PAI-1
Application Summary :
ELISA - This antibody can be used in ELISA with the appropriate secondary reagents to detect human PAI-1
Storage :
Store at –20°C. For long-term storage, aliquot and freeze at -70°C. Avoid repeated freeze/defrost cycles.
General References :
1. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cesari M, Pahor M, Incalzi RA. Cardiovasc Ther. 2010 28(5):e72-91. 2. The plasminogen activation system: new targets in lung inflammation and remodeling. Schuliga M, Westall G, Xia Y, Stewart AG. Curr Opin Pharmacol. 2013 13(3):386-93
more info or order :
company information
Toronto BioScience
info@torontobioscience.com
www.torontobioscience.com
headquarters: Canada